Whole body physiologically-based pharmacokinetic models: their use in clinical drug development

By Edginton Andrea N   Theil Frank-Peter   Schmitt Walter   Willmann Stefan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1143-1152

Informa Healthcare

Access to resources Recommend Favorite

Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM

By Langdon Grant   Gueorguieva Ivelina   Aarons Leon   Karlsson Mats  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 5, 2007-05 ,pp. : 485-498

Springer Publishing Company

Access to resources Recommend Favorite

Defining the Role of Macrophages in Local Moxifloxacin Tissue Concentrations using Biopsy Data and Whole-Body Physiologically Based Pharmacokinetic Modelling

By Edginton Andrea N.  

Clinical Pharmacokinetics, Vol. 48, Iss. 3, 2009-01 ,pp. : 181-187

Adis International

Access to resources Recommend Favorite

Whole Body Pharmacokinetic Models

By Nestorov I.  

Clinical Pharmacokinetics, Vol. 42, Iss. 10, 2003-01 ,pp. : 883-908

Adis International

Access to resources Recommend Favorite

Physiologically Based Pharmacokinetic Modeling of a Homologous Series of Barbiturates in the Rat: A Sensitivity Analysis

By Nestorov Ivan A.   Aarons Leon J.   Rowland Malcolm  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 4, 1997-08 ,pp. : 413-447

Springer Publishing Company

Access to resources Recommend Favorite